[Therapy of recurrent Herpes simplex].
D005060:Europe; D005260:Female; D005500:Follow-Up Studies; D006561:Herpes Simplex / Q000453:epidemiology / Q000276:immunology / Q000628:therapy*; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology; D007116:Immunization, Passive; D008297:Male; D011379:Prognosis; D018139:Simplexvirus / Q000276:immunology; D013997:Time Factors; D014611:Vaccination / Q000009:adverse effects; D014765:Viral Vaccines / Q000627:therapeutic use
D014765:Viral Vaccines
Die Behandlung des rezidivierenden Herpes simplex.